Annelotte van Bommel

56 REFERENCES 1. Netherlands Comprehensive Cancer Organisation. http://www.cijfersoverkanker. nl. [Accessibility verified September 14, 2017]. 2. Aalders KC, van Bommel AC, van Dalen T, et al. Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer. Eur J Cancer(Oxford,England).Aug2016;63:118–126. 3. NABONBreastCancerAudit.nbca.clinicalaudit. nl. [Accessibility verified September 14, 2017]. 4. van Bommel AC, Spronk PE, Vrancken Peeters MT, et al. Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands:ThenationalNABONBreastCancer Audit.JSurgOncol.2017;115(3):243–249. 5. Killelea BK, Yang VQ, Mougalian S, et al. Neo- adjuvant chemotherapy for breast cancer increases the rate of breast conservation: results from the National Cancer Database. J AmColl Surg. Jun 2015;220(6):1063–1069. 6. Heys SD, Hutcheon AW, Sarkar TK, et al. Neo- adjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial. Clin Breast Cancer. Oct 2002;3 Suppl 2:S69–74. 7. Freitas-Junior R, Gagliato DM, Moura Filho JWC, et al. Trends in breast cancer surgery at Brazil’s public health system. J SurgOncol. Apr 2017;115:544–549. 8. Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early- stage breast cancer. JAMA Surg. Jan 2015;150:9–16. 9. AhnSH,YooKY.Chronologicalchangesofclinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. BreastCancerResTreat.Sep2006;99:209–214. 10. Schrodi S, Niedostatek A, Werner C, Tillack A, Schubert-Fritschle G, Engel J. Is primary surgery ofbreast cancer patients consistent with German guidelines? Twelve-year trend of population based clinical cancer registry data. Eur J Cancer Care. Mar 2015;24:242–252. 11. Garcia-Etienne CA, Tomatis M, Heil J, et al. Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi- institutional European database. Eur J Cancer (Oxford, England). Sep 2012;48:1947–1956. 12. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. Oct 2009;16:2682–2690. 13. Dragun AE, Huang B, Tucker TC, Spanos WJ. Increasing mastectomy rates among all age groups for early stage breast cancer: a 10-year study of surgical choice. Breast J. Jul–Aug 2012;18:318– 325. 14. Habermann EB, Abbott A, Parsons HM, Virnig BA, Al-RefaieWB, Tuttle TM. Aremastectomy rates really increasing in the United States? J Clin Oncol. Jul 20 2010;28:3437–3441. 15. Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol. May 2013;20:1436–1443. 16. Chiu AS, Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR. Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB). Am J Surg. Jul 18 2017. 17. van Steenbergen LN, van de Poll-Franse LV, Wouters MW, et al. Variation in management ofearlybreastcancer intheNetherlands,2003– 2006. Eur J Surg Oncol. Sep 2010;36 18. Greenberg CC, Lipsitz SR, Hughes ME, et al. Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg. Aug 2011;254:339–345. 19. Rahal R, Chadder J, DeCaria K, Lockwood G, BryantH.Howdifferent iscancercontrolacross Canada? Comparing performance indicators for prevention, screening, diagnosis, and treatment. Curr Oncol. Apr 2017;24:124–128.